Using diaphragmatic ultrasound to diagnose acute respiratory distress in emergency patients
Official title: Evaluation of the Relevance of Diaphragmatic Stroke Ultrasound for the Etiological Diagnosis of Acute Respiratory Distress in an Emergency Department: a Prospective Multicenter Study.
Run by University Hospital, Montpellier · NCT06650137 · Data updated 2026-11-12
This study is testing if using diaphragmatic ultrasound can help doctors quickly diagnose pneumonia and other breathing problems in emergency patients who are having trouble breathing.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 2 sites (Nîmes, Gard and 1 other locations) |
| Status | Recruiting |
| Started | November 27, 2024 |
| Main results expected | November 1, 2026 |
| Study ends | November 1, 2026 |
| Registry record updated | December 6, 2024 |
| Trial ID | NCT06650137 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who are experiencing acute respiratory distress with specific clinical signs and symptoms.
✕Probably not a fit
Patients who are unable to provide consent or are under legal protection will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional multicenter diagnostic study aims to evaluate the effectiveness of diaphragmatic ultrasound as a diagnostic tool for patients experiencing acute respiratory distress in emergency departments. The primary focus is on measuring the Sum of Plateau Times (SPT) to diagnose pneumonia during acute respiratory distress. Secondary objectives include assessing other ultrasound parameters and their relevance in diagnosing conditions like chronic obstructive pulmonary disease and acute cardiogenic pulmonary edema. Eligible patients will undergo a diaphragmatic ultrasound performed by trained physicians, followed by the collection of clinical and biological data from medical records.
Why it matters
Potential benefit: If successful, this approach could lead to faster and more accurate diagnoses of pneumonia and other respiratory conditions in emergency settings.
How similar studies have gone: While diaphragmatic ultrasound has not been extensively studied in emergency settings, similar ultrasound techniques have shown promise in diagnosing respiratory conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 18 years of age or older; * Patient with ARD defined by respiratory rate (RR) strictly superior to 25 and/or signs of struggle which are: thoraco-abdominal rocking, active abdominal breathing, recruitment of extra-diaphragmatic respiratory muscles AND * peripheral saturation (SpO2) strictly inferior to 90% and/or hypercapnic acidosis (pH strictly inferior to 7.35 and pCO2 strictly superior to 45mmHg) on arterial blood gases; * Spontaneous ventilation. * Patients presenting a clinical severity score of Grade 1 with signs of struggle, as well as those with Grade 2 and Grade 3. A clinical severity score will be used as follows: Grade 1: Minimal polypnoea with respiratory rate (RR) between 20 and 25 ; Grade 2: Moderate polypnoea with respiratory rate (RR) between 25 and 35; Grade 3: Major polypnoea with respiratory rate (RR) between 35 to 50. Exclusion Criteria: * Adult protected by law (guardianship, curatorship, legal protection) * Refusal of consent after information * Patient on non-invasive ventilation ; * Patient on mechanical ventilation; * Respiratory rate superior to 50/min * Patient currently being treated for infectious pneumopathy with antibiotics; * Pregnant or breast-feeding women; * Patients with any known history of diaphragmatic pathologies. * Illiterate or unable to understand the purpose and methodology of the study. * Patient not affiliated to a social security scheme or not benefiting from such a scheme. * Person deprived of liberty (by judicial or administrative decision, or forced hospitalization) * Person participating in another study with an exclusion period still in progress,
Where it's running
-
University Hospital of Montpellier
Montpellier, Hérault, France Recruiting -
University Hospital of Nîmes
Nîmes, Gard, France Not yet recruiting
Study contacts
- Principal investigator: Dino Tikvesa, Md — University Hospital, Montpellier
- Study coordinator: Dino Tikvesa, Md
- Email: d-tikvesa@chu-montpellier.fr
- Phone: 0467337974
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sodium bicarbonate with bedside electrical impedance tomography to map lung blood flow in ventilated adults
This project will try whether a small sodium bicarbonate injection combined with bedside electrical impedance tomography can map lung blood flow in adults on mechanical ventilation, compared with hypertonic saline.
-
Safety and performance of the INBENTUS VERSATILE ventilator in adults on invasive mechanical ventilation
This trial will test whether the INBENTUS VERSATILE ventilator is safe and performs well in adults who need assisted or controlled invasive mechanical ventilation and short-term weaning.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
AI-powered CT help to guide pneumonia care
A multicenter trial tests whether using a chest CT–based AI report to guide care reduces death or need for new organ support in adults with pneumonia.
-
Wintergreen oil inhalation for shortness of breath in pneumonia patients
Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.
-
Optimising Antibiotic Use for Paediatric LRTIs in Africa
This study tests whether using point-of-care CRP tests together with the PREPARE score can safely reduce antibiotic use in infants aged 2–24 months with lower respiratory infections in a Johannesburg hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.